Device Authority targets a more practical route into automotive cybersecurity spending

Tern plc

Device Authority is trying to make its Industry Proof of Value relevant at a point when automotive cybersecurity is becoming a more immediate operational issue for manufacturers and suppliers. The company’s argument is straightforward. PKI and key management are no longer just technical matters. As vehicle architectures become more software-defined and connected, and as regulatory requirements tighten, control over cryptographic processes is moving closer to the centre of how OEMs manage risk, compliance and production.

Device Authority is offering a defined way for OEMs and Tier 1 suppliers to test how secure device identity, certificate lifecycle management, key generation, storage, distribution and BYOK models would work in practice. The point of the PoV is to move discussions away from theory and into a measurable operating model without requiring a full deployment at the outset.

This makes the proposition easier to understand commercially. In markets where decision cycles are long and implementation risk is closely scrutinised, a structured proof environment can help customers test both technical fit and regulatory relevance before making a wider commitment. That is important because buyers in this area are not simply looking for another cybersecurity product. They are trying to establish whether they can show control, retain visibility and support production at scale under tighter compliance expectations.

Device Authority is also placing clear emphasis on regulatory alignment. The source says the PoV is designed to map technical outcomes to requirements such as cryptographic governance, certificate traceability, secure lifecycle controls, production auditability and rapid revocation and update capabilities.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Device Authority strengthens position in machine identity and Zero Trust Security

Device Authority’s inclusion in two 2026 Gartner Hype Cycle reports reinforces its positioning in machine identity, IoT authentication and Zero Trust security.

Talking Medicines highlights strategic value of patient journey intelligence

Patient journey intelligence can help healthcare organisations identify care barriers and design more responsive pathways around real patient experiences.

Evidence-based care pathways support more consistent healthcare delivery

Evidence-based care pathways can improve diagnosis, treatment consistency and the integration of new therapies into routine care.

Tern increases Talking Medicines funding and raises shareholder distribution commitment

Tern has invested in additional Talking Medicines convertible loan notes and increased its minimum shareholder distribution commitment to 70% on qualifying exits.

Evidence-based care pathways create clearer routes to adoption

Evidence-based care pathways can reduce delays, improve treatment consistency and support the adoption of new therapies.

Talking Medicines highlights the data opportunity emerging around GLP-1 care

Talking Medicines examines how the expanding GLP-1 market is increasing the importance of clear distinctions between approved therapies, compounded medicines and nutritional support.

Search